Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peptide-based gene delivery.

R I Mahat1, O D Monera, L C Smith

  • 1Copernicus Therapeutics Inc, Cleveland, Ohio 44106-3052, USA. rmahato@cgsys.com

Current Opinion in Molecular Therapeutics
|November 22, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the adequacy of current dietary guidelines for seafood as a source of long-chain omega-3 fatty acids.

Scientific reports·2026
Same author

Etiology of lipid-laden macrophages in the lung.

International immunopharmacology·2023
Same author

Microendoscopic transventricular deep brain stimulation of the anterior nucleus of the thalamus as a safe treatment in intractable epilepsy: A feasibility study.

Revue neurologique·2022
Same author

The CHALLENGE trial: the effects of a virtual reality-assisted exposure therapy for persistent auditory hallucinations versus supportive counselling in people with psychosis: study protocol for a randomised clinical trial.

Trials·2022
Same author

Prenatally Symptomatic Suprasellar Arachnoid Cyst: When to treat? A case-base update.

Neuro-Chirurgie·2022
Same author

Decreasing surface albedo signifies a growing importance of clouds for Greenland Ice Sheet meltwater production.

Nature communications·2022
Same journal

Gene therapy: Have the risks associated with viral vectors been solved?

Current opinion in molecular therapeutics·2011
Same journal

Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.

Current opinion in molecular therapeutics·2010
Same journal

Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes.

Current opinion in molecular therapeutics·2010
Same journal

Corticorelin, a synthetic human corticotropin-releasing factor analog, for the treatment of peritumoral brain edema.

Current opinion in molecular therapeutics·2010
Same journal

Mogamulizumab, a humanized mAb against C-C chemokine receptor 4 for the potential treatment of T-cell lymphomas and asthma.

Current opinion in molecular therapeutics·2010
Same journal

Gevokizumab, an anti-IL-1β mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease.

Current opinion in molecular therapeutics·2010
See all related articles

Synthetic peptides show promise for improving gene therapy by enhancing plasmid delivery. These peptides can overcome key barriers like endosomal escape and nuclear entry, making gene transfer more effective.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Gene Therapy

Background:

  • Effective plasmid-based gene therapy requires overcoming cellular barriers including uptake, trafficking, and nuclear retention.
  • Key limitations include inefficient endosomal release, cytoplasmic transport, and nuclear entry of plasmids.
  • Current non-viral methods often involve complexation with cationic lipids or polymers.

Purpose of the Study:

  • To explore peptide-DNA interactions in gene delivery.
  • To assess the potential of peptides for efficient gene transfer.
  • To review the use of peptides in enhancing existing gene delivery systems.

Main Methods:

  • Review of conceptual and experimental aspects of peptide-DNA interactions.
  • Critical assessment of peptide-based gene transfer efficiency.

Related Experiment Videos

  • Overview of peptide applications in multicomponent gene delivery complexes.

    • Main Results:

    • Peptides can be integrated into gene delivery complexes for DNA condensation, targeting, endosomolysis, and nuclear transport.
    • Synthetic peptides represent an under-explored but potent class of gene delivery agents.
    • Peptide-based systems offer significant potential for commercial gene delivery products.

    Conclusions:

    • Peptide-based gene delivery systems demonstrate considerable potential for effective and viable gene therapy applications.
    • Strategic incorporation of peptides can enhance plasmid delivery by addressing critical cellular barriers.
    • Further research into peptide-DNA interactions is crucial for optimizing gene transfer efficacy.